Integral Derivatives’s Silver Standard Resources SSRI Stock Holding History

Integral Derivatives’s Portfolio SSRI Stock Details SSRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-15,700	Closed	-$152K	–	1386
2017 Q2	$152K	Buy	15,700 +5,700	+57%	+$57.3K	﹤0.01%	1011
2017 Q1	$106K	Sell	10,000 -700	-7%	-$7.41K	﹤0.01%	1078
2016 Q4	$95K	Sell	10,700 -3,600	-25%	-$36.4K	﹤0.01%	1066
2016 Q3	$172K	Buy	14,300 +200	+1%	+$2.7K	﹤0.01%	912
2016 Q2	$183K	Buy	+14,100	New	+$131K	﹤0.01%	847
2014 Q1	–	Sell	-42,200	Closed	-$294K	–	1823
2013 Q4	$294K	Buy	+42,200	New	+$255K	﹤0.01%	1223

Other funds holding SSRI

SCP

Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Integral Derivatives's SSRI Position: Q3 2017 in Review

Integral Derivatives sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 10,294 shares — an estimated $100K sold.

Integral Derivatives first reported a position in SSRI in Q1 2014 and held it in 2 quarters. The position peaked at $125K in Q1 2014. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

Integral Derivatives reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
Integral Derivatives sold 10,294 Silver Standard Resources shares in Q3 2017, an estimated $100K.
Integral Derivatives first reported a position in Silver Standard Resources in Q1 2014 and held it in 2 quarters.
Integral Derivatives's Silver Standard Resources position peaked at $125K in Q1 2014.
1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.